Aguado, Héctor J. http://orcid.org/0000-0002-0371-6720
Castillón-Bernal, Pablo http://orcid.org/0000-0003-2348-0863
Ventura-Wichner, Paula S. http://orcid.org/0000-0002-7981-8491
Cervera-Díaz, María C. http://orcid.org/0000-0003-4476-9252
Abarca-Vegas, Javier
García-Flórez, Luis http://orcid.org/0000-0001-7030-9888
Salvador-Carreño, Jordi http://orcid.org/0000-0003-3361-2567
García-Virto, Virginia http://orcid.org/0000-0002-7609-7991
Simón-Pérez, Clarisa http://orcid.org/0000-0002-3858-0325
Ojeda-Thies, Cristina http://orcid.org/0000-0001-7052-1491
Sáez-López, Pilar http://orcid.org/0000-0002-9467-7746
González-Montalvo, Juan I. http://orcid.org/0000-0001-9213-0619
,
Funding for this research was provided by:
Fundación Mapfre
Fundación Mutua Madrileña (AP169672018)
Amgen Foundation
UCB Pharma
Abbott Nutrition
FAES Farma
Article History
Received: 7 December 2021
Accepted: 26 February 2022
First Online: 26 March 2022
Declarations
:
: All participating centres in the Spanish hip fracture registry Registro Nacional de Fracturas de Cadera (RNFC) received approval from their local ethics committees or local institutional review boards. This study has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. All patients included in the registry (RNFC) gave their prior informed consent.
: Not applicable.
: Héctor J. Aguado, Pablo Castillón-Bernal, Paula S. Ventura-Wichner, Carmen Cervera-Díaz, Javier Abarca-Vegas, Luis García Flórez, Jordi Salvador-Carreño, Virginia García-Virto, Clarisa Simón-Pérez, Cristina Ojeda-Thies, Pilar Sáez-López and Juan I. González-Montalvo have no personal or commercial association (e.g. consultancies, stock ownership, equity interest, patent, licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article. The authors declare that they have no competing interests.